07:00 , Jun 25, 2012 |  BC Week In Review  |  Company News

Atherotech, BG Medicine sales and marketing update

Atherotech began offering BG Medicine's BGM Galectin-3 test in the U.S. to aid in assessing the prognosis of patients diagnosed with chronic heart failure (CHF). BG Medicine markets the test in Europe to aid in...
07:00 , Jun 11, 2012 |  BC Week In Review  |  Company News

Arup Laboratories, Atherotech, Critical Diagnostics, Health Diagnostic Laboratory, Mayo Clinic sales and marketing update

Atherotech, Arup, Health Diagnostic, and Mayo Clinic's Mayo Medical Laboratories will begin offering Critical Diagnostics' Presage ST2 assay testing services to aid in assessing the prognosis of patients diagnosed with chronic heart failure (CHF). Each...
08:00 , Jan 30, 2012 |  BC Week In Review  |  Clinical News

Vertical Auto Profile diagnostic data

Researchers at Thomas Jefferson University reported data from a 2-year retrospective study in 2,056 patients with congestive heart failure (CHF) or ischemic heart disease showing that patients whose treatment protocol incorporated comprehensive lipid profiling with...
08:00 , Jan 30, 2012 |  BC Week In Review  |  Company News

Atherotech management update

Atherotech Diagnostics Lab Inc. , Birmingham, Ala.   Business: Diagnostic   Hired: Joseph Chimera as EVP of scientific development, formerly general manager of clinical trials lab division at Laboratory Corp. of America Holdings  ...
08:00 , Dec 5, 2011 |  BC Week In Review  |  Company News

Atherotech management update

Atherotech Diagnostics Lab Inc. , Birmingham, Ala.   Business: Diagnostic   Hired: Charles Musial as CFO, a newly created position, formerly CFO of Laboratory Partners Inc.  ...
07:00 , Jul 4, 2011 |  BC Week In Review  |  Company News

Atherotech, GlycoMark Inc. sales and marketing update

Atherotech and GlycoMark will co-commercialize Atherotech's Vertical Auto Profile (VAP) Cholesterol Test with GlycoMark's GlycoMark diabetes test in the U.S. Financial terms were not disclosed. The VAP test measures 22 cholesterol components plus markers of...
08:00 , Jan 24, 2011 |  BC Week In Review  |  Company News

Atherotech deal

Private equity firm Behrman Capital acquired Atherotech for an undisclosed sum. Atherotech markets its Vertical Auto Profile (VAP) advanced lipid profile test, which measures lipid subclasses that cause cardiovascular disease. Robert Flaherty, operating partner at...
07:00 , Mar 16, 2009 |  BC Week In Review  |  Company News

Atherotech Inc. sales and marketing update

Atherotech added the apolipoprotein A-1 (APOA1) marker to its marketed VAP (vertical auto profile) Cholesterol Test to assess the risk of heart disease and diabetes. The test also measures apolipoprotein B (APOB) . Atherotech Inc....
07:00 , May 14, 2007 |  BC Week In Review  |  Company News

Atherotech Inc. board of directors update

Atherotech Inc. , Birmingham, Ala.   Business: Diagnostic   Appointed: Laura King, former president and CEO of General Electric Co. 's GE Healthcare Interventional Cardiology business unit; and Kenneth Roe, former regional VP and operations...
08:00 , Feb 5, 2007 |  BC Week In Review  |  Company News

Atherotech Inc. board of directors update

Atherotech Inc. , Birmingham, Ala.   Business: Diagnostic   Appointed: Kneeland Youngblood, managing partner at Pharos Capital Group LLC, as chairman  ...